Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 24, 2011 01:37 ET | Source: Evotec AG

Evotec and Roche to Jointly Develop Biomarkers in Oncology

HAMBURG, Germany and BASEL, Switzerland, June 24, 2011 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) and Roche (SIX:RO) (SIX:ROG) (OTCQX:RHHBY) today announced a collaboration in novel...
June 06, 2011 01:42 ET | Source: Evotec AG

Evotec and Active Biotech Enter Into Medicinal Chemistry Collaboration

HAMBURG, Germany, June 6, 2011 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) today announced that it has entered into a medicinal chemistry collaboration with Active Biotech AB...
June 01, 2011 02:26 ET | Source: Evotec AG

Evotec Acquires Compound Management Business From Galapagos

EVOTEC TO FURTHER STRENGTHEN ITS INTEGRATED INNOVATION OFFERING WITH WORLD-CLASS COMPOUND MANAGEMENT SYNERGIES WITH EVOTEC'S DRUG DISCOVERY ALLIANCE BUSINESS EXPECTED €12.5...
May 31, 2011 01:49 ET | Source: Evotec AG

Evotec Receives Milestone as Boehringer Ingelheim Starts Phase I Clinical Trial in Pain

HAMBURG, Germany, May 31, 2011 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) today announced that a back-up compound in its strategic alliance with Boehringer Ingelheim has advanced into a...
May 25, 2011 01:38 ET | Source: Evotec AG

Evotec and PsychoGenics Enter Into a Strategic Alliance to Provide Integrated CNS Drug Discovery Solutions

HAMBURG, Germany, May 25, 2011 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) today announced that it has entered into a strategic alliance with PsychoGenics Inc. to provide integrated CNS...
May 18, 2011 05:42 ET | Source: Evotec AG

Phase II Study With NR2B Sub-Type Selective NMDA Antagonist in Treatment-Resistant Depression Voluntarily Terminated

HAMBURG, Germany, May 18, 2011 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) and Roche (SWX:RO) (SWX:ROG) (OTCQX:RHHBY) today decided to voluntarily terminate the first proof-of-concept study...
May 12, 2011 01:37 ET | Source: Evotec AG

Evotec Reports 54% Q1 Revenue Growth and Significant Expansion of Drug Discovery Alliance Business

HAMBURG, Germany, May 12, 2011 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) today reported financial results and corporate updates for the first quarter of 2011. Strong Q1 growth;...
May 09, 2011 01:37 ET | Source: Evotec AG

Evotec Receives Twelfth Milestone Payment as Part of Its Discovery Alliance With Boehringer Ingelheim

HAMBURG, Germany, May 9, 2011 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) today announced that its research alliance with Boehringer Ingelheim has achieved a twelfth milestone triggering a...
May 04, 2011 09:58 ET | Source: Evotec AG

Evotec to Report First Quarter 2011 Results on 12 May 2011

HAMBURG, Germany, May 4, 2011 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT), (TecDAX) will report its financial results for the first quarter of 2011 on Thursday, 12 May 2011. The Company is going...
April 19, 2011 01:48 ET | Source: Evotec AG

Evotec Completes Acquisition of Kinaxo Biotechnologies GmbH

HAMBURG, Germany, April 19, 2011 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) today announced that it has completed the acquisition of Kinaxo Biotechnologies GmbH, a privately held drug...